Degarelix
Degarelix for Prostate Cancer Treatment
A leading therapy for effective advanced prostate cancer management.
Degarelix for Hormone Therapy
Targeting hormone-driven cancers with proven high efficacy.
Degarelix's Therapeutic Benefits
Effective in reducing testosterone levels and managing symptoms.
Advancing Cancer Care with Degarelix
Partner with us to improve outcomes for prostate cancer patients.
D-Hydroorotic Acid
D-Hydroorotic Acid is a key intermediate in the biosynthesis of pyrimidine nucleotides and plays an essential role in cellular metabolism. As a stereoisomer of hydroorotic acid, this compound is involved in the early stages of pyrimidine biosynthesis, where it undergoes further enzymatic transformations to yield orotidine monophosphate (OMP), a precursor for uridine monophosphate (UMP). Its importance is evident in both prokaryotic and eukaryotic organisms, contributing to the synthesis of DNA and RNA.
D-Hydroorotic Acid is often used in biochemical research to study nucleotide metabolism and pyrimidine biosynthesis pathways. It is also of interest in pharmaceutical development, particularly for the design of drugs targeting nucleotide metabolism and cancer therapies, as well as antiviral agents.
CAS No: 5988-53-4
>>Download COA
Application:
- Biochemical Research: Used in studies of pyrimidine biosynthesis and nucleotide metabolism.
- Pharmaceutical Development: Investigated for its potential in the design of therapies targeting nucleotide metabolism, cancer, and viral infections.
- Metabolic Studies: A crucial molecule in understanding cellular processes related to DNA and RNA synthesis.
Packing: Customized
Need more information/samples?